|
|
Office Locations:
|
1700 Owens Street
San Francisco, CA 94158
Phone: 650-888-8161
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
The Longevity Fund is a Seed and Series A VC with $37M under management, investing in breakthrough longevity companies. The firm targets pharmaceutical companies developing therapies for aging-associated pathology. The fund seeks to improve the quality of life for aging populations and their caregivers and lower costs to society. For the Longevity Fund I, the firm aims to make 5-10 investments in the U.S. in the range $100K to $1M.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
